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Summary
Disorders of cholesterol biosynthesis have clinical manifestations involving skeleton, 
eyes, neurologic development, and skin1. We describe a patient with congenital cataracts, 
developmental delay, microcephaly, and low serum cholesterol who developed severe 
psoriasiform dermatitis and arthralgias beginning at age 3. Her brain MRI indicated 
minor gliosis. Quantitative sterol analysis of patient plasma and skin showed marked 
elevation of 4D-methyl- and 4, 4’-dimethylsterols, indicating a deficiency in the first step 
of sterol C4 demethylation in cholesterol biosynthesis. Molecular studies showed 
mutations in SC4MOL, a gene predicted to encode a sterol C4 methyl oxidase. Thus, our 
patient has a previously undescribed inborn error of cholesterol biosynthesis. Cellular 
studies with patient-derived fibroblasts showed higher mitotic rate than control cells in 
cholesterol-depleted medium, in which de novo cholesterol biosynthesis was increased 
with the accumulation of methylsterol. Immunologic analyses showed dysregulation of 
immune-related receptors in the patient and her father. Inhibition of sterol C4 methyl 
oxidase in human transformed lymphoblasts or in fresh leukocytes induced activation of 
cell cycle, and immune receptor dysregulation . These findings suggest that methylsterols 
influence mitotic capacity and immune function. SC4MOL is situated within the psoriasis 
susceptibility locus PSORS92, and is likely a genetic risk factor for common psoriasis. 
The patient was seen in our clinic at the age of 13. She had a severe dermatitis affecting 
her entire body, sparing the palms (Fig 1a-c). Skin biopsy was characteristic of 
psoriasiform dermatitis (Fig 1d). While her skin briefly improved with cyclosporine A 
treatment, she did not respond to other treatments including topical corticosteroids,
dovonex, etanercept, phototherapy, and oral isotretinoin. The refractory nature of her skin 
disease, and mild developmental and growth delay with delayed skeletal maturation, a 
history of multiple allergies, mild arthritis, and frequent infections, prompted further 
evaluation. She had markedly elevated levels of serum IgE at 1,486 IU/ml (normal <180) 
and IgA at 684 IU/ml (normal <218). Her serum lipid profile showed only a persistently 
low total cholesterol level (Fig 2c).
A cholesterol biosynthesis defect was suspected. Analysis of plasma sterols by gas 
chromatography-mass spectrometry (GC-MS) showed 20- and 500-fold elevation of 4D-
monomethyl sterols and 4, 4’-dimethyl sterols, respectively (Fig 2a).  This pattern of 
elevation has not been previously associated with a defect in the sterol synthesis pathway, 
but was consistent with a defect in a methylsterol oxidase.  
Therefore, we sequenced the SC4MOL gene that was predicted to encode this enzyme. 
Two variations from the published sequence were identified; 519T>A and 731A>G 
encoding H173Q and Y244C, respectively, in the sterol C4 methyl oxidase-like protein 
(Fig 3a), herein referred to as sterol methyl oxidase (SMO). The 519T>A mutation was 
carried by the patient’s father, and the 731A>G was carried by the mother. Both amino 
acids occur within highly conserved metal-binding domains in SMO (Fig 3b). In 
addition, H173Q alters a predicted active site of the second iron-binding motif of the 
enzyme.   
Plasma methylsterol levels were also elevated in the patient’s parents (Fig 2c). This 
suggests a subclinical effect for heterozygotes, in keeping with that seen in carriers of a 
DHCR14B/LBR mutation who have altered nuclear morphology in granulocytes (Pelger-
Huët anomaly)3. DHCR14B/LBR encodes C14-sterol reductase, immediately upstream of 
SMO, which also functions as a nuclear lamin B receptor4. Tight regulation of these two 
enzymes in the pathway underscores extra-sterol functions of 4, 4’-dimethylsterols.  
The two most abundant dimethylsterols; 4, 4’-dimethyl-5D-cholesta-8,24-dien-3E-ol 
(testis-meiosis activating sterol (MAS)), and 4, 4’-dimethyl-5D-cholesta-8, 14, 24-trien-
3E-ol (follicular fluid -MAS), substrates for SMO and C14-sterol reductase respectively, 
are members of the MAS family and are found in high concentration in testis and ovary. 
The underlying mechanism of their extra-sterol function remains unknown. However 
since 4, 4’-dimethylsterols are either direct substrates or products of C14 sterol reductase, 
they could function as signaling sterols for nuclear lamin B receptor. The nuclear lamin B 
receptor is important for nuclear membrane breakdown during meiosis of germinal 
cells5,6 and formation of the mature granulocyte nucleus7. Granulocyte/neutrophil-rich 
pathology is characteristic of psoriasis and psoriatic arthritis8,9. Thus the mild elevation of 
4, 4’-dimethylsterols seen in the patient’s father could be relevant to his history of mild 
inflammatory joint disease and a paternal family history of early onset inflammatory joint 
disease (Supplementary Fig 1 online).
Skin cell hyperproliferation causes flaking skin, characteristic of psoriasis. All known 
genetic disorders that cause increased levels of MASs, including defects in 
DHCR14/LBR, NSDHL and EBP (Fig 2b)1,10,11, present with ichythyosiform/psoriasiform 
dermatitis in humans and mice. However, none of the defects adjacent or distal to MAS 
demethylation complex, including CYP51, SC5D, or DHCR7, manifest skin lesions 12-14.
Previous studies of germinal cells have demonstrated meiosis-activating function of MAS 
15,16, but the effect of MAS on cell cycle regulation and mitosis is unknown.  
Therefore, we examined cell proliferation in patient skin fibroblasts (Fig 4a-c). The rate 
of cell division was found to be higher in patient fibroblast than control cells cultured in 
cholesterol-depleted medium, a condition under which de novo cholesterol biosynthesis is 
stimulated (Fig 4a). The S-G2-M to G0-G1 ratio in patient skin fibroblasts was >3-fold 
higher than control cells (Fig 4b). This ratio peaked after 2-3 days growth in the 
cholesterol-depleted medium, and corresponded with peaks of cellular methylsterols and 
total protein (Supplementary Table 1 online).
Growth of patient cells in cholesterol-depleted suggest association between MAS and cell 
division. To further examine this possibility, transformed human lymphoblasts were 
cultured in the presence of a SMO inhibitor, 3-amino-1,2,4-triazole (ATZ). Under these 
conditions, the cells accumulated a profile of methylsterols similar to that of the patient’s 
lymphocytes grown without ATZ (data not shown). Parallel to this, the S-G2-M/G0-G1 
ratio increased 3-fold in treated lymphoblasts, while neither simvastatin or fluconazole 
(an inhibitor of lanosterol 14D demethylase (CYP51)) had a significant effect on cell 
cycle progression (Fig 4c). These data indicate alterations in SMO that in turn affects cell 
cycle activation.
Patients with genetic defects in NSDHL, which encodes the enzyme immediately 
downstream of SMO, occasionally present with symptoms nearly identical to those with 
defects in EBP1,10,11 and vice versa; but they always differ in skin histopathology. Out of 
newborn period, NSDHL-deficient patients have psoriasiform dermatitis whereas EBP-
deficient patients have ichthyosis, a condition associated with minor skin inflammation. 
Our patient, and NSDHL-deficient patients accumulate 4, 4’-dimethylsterols in their skin, 
but EBP-deficient patients do not. This suggests that dimethylsterols differ from other 
MAS in contributing to the perturbation of immune function. SC4MOL is located on 
4q32-34, the known psoriasis susceptibility locus PSORS9 (4q31-34). Histologically, our 
patient’s dermatitis is identical with that seen in classical psoriasis. 
Since both the patient and her father had a significant elevation of dimethylsterols, we 
examined a comprehensive panel of immunologic parameters as described in the methods 
and Supplementary Table 2 online. Selected multicolor flow cytometry profiles of 
granulocytes and T cells are shown in Figure 4d, and the geometric mean fluorescence 
intensity, and percentage of cells for each measurement are shown in Supplementary 
Table 3 online. 
We found that activated CD16+ granulocytes; identified by CD25+CD69+ and 
CD86+HLA-DR+ subsets; were increased 30- and 20-fold in the patient and father, 
respectively, compared with healthy controls (Fig 4d and Supplementary Table 3
online). In addition, there was 30- and 15-fold increased numbers of toll-like receptor 
(TLR)-2+TLR-4- granulocytes in the patient and father, respectively, compared with 
healthy controls (Fig 4d). Up-regulation of TLR-2, but not TLR-4, is considered typical 
for patients with psoriasis17 or psoriatic arthritis18. Over-expression of TLR-2 and down-
regulation of TLR-4 on granulocytes suggest perturbation of innate immune responses to 
bacterial infection. Consistent with this observation, expression of granulocyte-specific, 
CD16b isoform was also markedly down-regulated in both patient and father (Fig 4e),
suggesting a defect in phagocytic function. 
In the lymphocyte compartment, both patient and father had significantly higher 
proportions of CD8dim T cells that were also CD28nullCD56+ (Fig 4d, Supplementary 
Table 3). Down-regulation of CD8 and CD28, and accumulations of CD28nullCD56+ T 
cells are indicative of pervasive immune activation in the setting of chronic inflammatory 
disease 19.
We then examined whether inhibiting SMO by ATZ affected normal leukocytes. Results 
showed over 6-fold increase in TLR-2+TLR-4- granulocyte population (Fig 4f), and 2-
fold decrease in CD8 expression in normal lymphocytes (Supplementary Table 4
online). These results recapitulated the in vivo granulocyte and T cell phenotypes of the 
patient and father (Fig 4d). All these data indicate a link between cholesterol homeostasis 
and immunity. 
Because psoriasis and psoriatic arthritis are known to be driven by the production of 
certain cytokines, including tumor necrosis factor (TNF)-D and interleukin (IL)-6, the 
serum cytokine profiles of the patient and father were investigated by multiplex assay 
(Supplementary Table 5 online). Consistent with the flow cytometry data, a number of 
cytokines and chemokines associated with granulocyte and monocyte activation were 
elevated in the patient, and to a lesser extent in her father. This included granulocyte and 
monocyte colony stimulation factor, which is known to trigger psoriasiform eruption in 
humans20. The patient also had elevated IL-6 and IL-8 (Supplementary Table 5 online),
cytokines that amplify skin inflammation as has been demonstrated in psoriatic skin and 
fibroblasts21.
The classical pro-inflammatory cytokine TNF-D was normal in the patient, consistent 
with the fact that her dermatitis did not respond to treatment with etanercept. Cultures of 
patient skin fibroblasts showed constitutive production of IL-6 compared to control 
fibroblasts regardless of passage number (Fig 4g), and were further increased with the 
addition of recombinant TNF-Da known inducer of IL-6. To investigate a possible 
association of the defect in cholesterologenesis and cytokine production, we treated 
control and patient fibroblasts with simvastatin, which blocks cholesterol biosynthesis 
upstream of SMO. After 24 hours, IL-6 production by patient fibroblasts was 
significantly decreased even in the presence of exogenous TNF-Į (Fig 4g), suggesting 
that the accumulated sterol intermediates in our patient were stimulating IL-6 production.   
In summary, we have identified the first patient deficient in SMO, a novel enzyme in the 
C4 methylsterol demethylation complex that is encoded by SC4MOL. Our data suggest a 
role for SMO in regulating granulocyte activation, CD8 expression on T cells, cytokine 
production, and cell proliferation, factors that are critical in the pathogenesis of common 
psoriasis. We have previously reported elevated methylsterols in skin flakes from patients 
with common psoriasis22. Thus variation in expression or function of SMO may be an 
important modifying factor in the development of common psoriasis.  
Methods
This study was conducted pursuant to an IRB protocols approved by the University of 
Pittstburgh.
Genomic DNA and cDNA amplification and sequencing. Total RNA and gDNA was 
extracted from patient fibroblasts for reverse transcription, PCR amplification, and 
sequencing as described 23. Six exons of SC4MOL were amplified using intronic primers 
(all primer sequences available upon request). 
Sterol analyses. Sterol distribution was measured in cultured skin fibroblasts, 
transformed lymphocytes, serum, or skin flakes obtained from patients and controls by 
GC and selected-ion MS as described11,24.
Flow cytometry on peripheral blood cells 
Flow cytometry on cells from patient and controls were carried out and analyzed as 
described previously 19,21. In the sterol oxidase inhibition studies, 10 ml of erythrocyte-
depleted blood from a healthy 16-year old girl was incubated with 5mM ATZ for 60 
hours at 37 degree with 5% C02, both ATZ treated and untreated total leukocytes were 
then isolated and stained as described in Supplementary Table 2 online.
Serum cytokine quantification. Cytokine levels were determined by multiplex assay 
using the Luminex system (Luminex Corporation) as described previously25,26.
Cell culture, proliferation and ELISA. 
Primary dermal fibroblasts were cultured in DMEM supplemented with 10% FBS, 100 
U/ml penicillin, 100 mg/ml streptomycin and GlutaMAX (Invitrogen), TNF-D (10ng/ml) 
and simvstastin (5PM) were added to fibroblasts at 80% confluency, and culture media 
were collected after 24 hours for measurement of IL-6 using an ELISA kit (BD 
Bioscience). For cell proliferation assays, primary fibroblasts or EBV-transformed human 
lymphoblasts were cultured with cholesterol-depleted medium as described24; and ATZ 
(2mM), simvstastin (5PM) or fluconazole (12.5PM) were added to the medium before the 
cells were subjected to the proliferation assay. 
Cell proliferation and cell cycle stage analysis 
Skin fibroblasts, or EBV-transformed lymphoblast (2 x 107 cells/ml) were labeled with 
0.25PM of 5- (and 6-) carboxyfluorescein diacetate succinimidyl ester (CFSE; Molecular 
Probes) using established procedures20. At different days of culture, cells were harvested 
and stained with 4',6'-diamidino-2-phenylindole (DAPI), and analyzed by multicolor flow 
cytometry. The number of cell divisions was determined by the number of CFSE 
fluorescence peaks. The number of cells in G0-G1 and in the S-G2-M phases of the cell 
cycle was proportional to the amount of linear DAPI fluorescence, G0-G1 cells having 
half the amount of DAPI staining as the S-G2-M cells. 
Figure Legend 
Figure 1. Severe, scaling,and psoriasiform dermatitis in the patient. a. Note mild 
microcephaly, lusterless fine fair hair, and blepharitis on face. b and c. The 
ichythyosiform erythroderma covers all of the patient’s body except for the palms and 
soles. d. H&E-stained section of affected skin shows hyperkeratosis, loss of granular 
layer, psoriasiform hyperplasia, thinning of suprapaillary plate, and neutrophilic 
epidermal infiltration; these features are characteristic of psoriasis. Photograph is shown 
per signed informed consent/assent provided by the patient and her family.  
Figure 2. Sterol profiles of patient samples and diagram of the sterol C4 demethylation 
pathway. a&b. Gas chromatographic flame ionization profiles of sterol extracts of patient 
skin (a) and plasma (b). The ordinates are detector response and elution time. The 
identified compounds are: 1, internal standard (epicoprostanol); 2, cholesterol; 3, 
lathosterol; 4, phytosterol; 5, campesterol; 6, 4D-methyl-5D-cholest-8(9)-en-3ȕ-ol; 7, 4D-
methyl-5D-cholest-7(8)-en-3ȕ-ol; 8, 4, 4’-dimethyl-D-cholesta-8(9)-en-3ȕ-ol; 9, 
lanosterol; 10, sitosterol; 11, 4, 4’-dimethyl-D-cholesta-8(9),24-dien-3ȕ-ol. Both 
dimethylsterols and monomethylsterols were markedly elevated in patient skin and 
plasma. Dimethylsterol (peak 8) is most elevated in skin suggesting the preferential 
accumulation of 4, 4’-dimethylsterols in the patient’s skin compared to plasma, which 
may explain the severe involvement of the patient’s skin. The absence of a 4-
carboxysterol in the skin excludes a possible defect in NSDHL. b, Diagram of the 
enzymatic pathway for conversion of lanosterol to cholesterol. The saturation of the C-24 
double bond may occur at different points in the pathway. The physiological function 
TM7SF2 is unclear27. c. Plasma sterol analysis and plasma total cholesterol levels from 
controls, the patient before cholesterol supplementation and after 3 months of cholesterol 
supplementation, and the patient’s mother and father. Methylsterols levels are the sum of 
both dimethylsterols and monomethylsterols. After 3 month of cholesterol 
supplementation, a 19% reduction in the patient’s plasma methylsterol level was seen, 
together with an increase of her total cholesterol level. After 6 month of cholesterol 
supplementation, the patient’s total cholesterol normalized, however no further reduction 
of methylsterols was seen (data not shown).
Figure 3. Mutation analysis of SC4MOL in proband and parental samples, and the 
alignment of amino acid sequences of SMO among different species.
a. Two mutations were identified in SC4MOL from both gDNA and cDNA extracted 
from peripheral blood leukocytes, T519>A and A731>G. T519>A was also identified in 
gDNA from patient’s father, and A731>G was identified in her mother. b. Alignment of 
SMO protein sequences across evolution. From yeast to human, SC4MOL is highly 
conserved. Four conserved metal-binding domains were identified and are highlighted 
with black squares. The conserved metal binding motifs HXXXH/D and HXXHH are 
marked under the alignment. T519>A changes amino acid  H173 to Q, which replaces the 
histidine at an active site of the second metal binding domain with glutamine; A731>G 
changes amino acid Y244 to C; Y244 is in the fourth metal binding domain and also is 
conserved across evolution. 
Figure 4. Fibroblast and immunocyte abnormalities in the patient and her father.
a,b: Fibroblasts were labeled with CFSE and DAPI, cultured, and analyzed by flow 
cytometry. The number of cell divisions was determined by the number of CFSE 
fluorescence peaks. The number of cells in G0-G1 and in the S-G2-M phases of the cell 
cycle was analyzed by the amount of linear DAPI fluorescence. c Histograms show 
typical DAPI fluorescence profiles of cells in G0-G1 and G2-S-M phases of the cell cycle 
in human EBV-transformed lymphoblasts cultured in standard FBS-supplemented media 
(FBS); or in cholesterol-depleted medium (CD); or in CD supplemented with either 
simvastatin (ST), 3-amino-1,2,4 triazole (ATZ), or fluconazole (FA). d,e: Leukocyte
populations were analyzed by multicolor flow cytometry; subsets  identified by 
forward/scatter profiles, with mature granulocytes, monocytes, and lymphocytes falling 
in gates A, B, and C, respectively. Data shown are cytometric profiles for CD25, CD69, 
CD86, HLA-DR, TLR-2, and TLR-4 (d), and fluorescence histograms of CD16b (e) for 
mature granulocytes/neutrophils. Also shown are the CD4, CD8, profiles of CD3+ T 
cells; and CD28null CD56+ in CD8dim T cells (gate D). No significant differences were 
observed in the monocyte population (data not shown). f. Cytometric profiles for TLR-2 
and TLR-4 on granulocytes of healthy control with (blue) or without (red) ATZ 
treatment. Overlay of cytograms show ATZ-induced phenotypic shift towards increased 
TLR-2 expression. g; IL-6 production by dermal fibroblasts from healthy control and 
patient upon treatment of TNF-D, and TNF-D plus simvastatin, or in media alone.
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